Filter Results
Clinical Studies
Results filtered:Study status:
Open
Closed for Enrollment
Closed for Enrollment
-
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing The Impact Of Olpasiran On Major Cardiovascular Events In Patients With Atherosclerotic Cardiovascular Disease And Elevated Lipoprotein (A)
Rochester, MN
The purpose of this study is to assess the impact of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease (ASCVD) and elevated lipoprotein (a) (Lp[a]) ≥ 200 nmol/L. The primary objective is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death, myocardial infarction, or urgent coronary revascularization in these patients.
-
Fiber and Diabetes (FAD) Study: Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markers in DM2
Rochester, MN
The purpose of this study is to assess whether psyllium is more effective in lowering fasting blood sugar and HbA1c, and to evaluate the effect of psyllium compared to wheat dextrin on the following laboratory markers: LDL-C, inflammatory markers such as ceramides and hsCRP, and branch chain amino acids which predict Diabetes Mellitus (DM).
-
Validating The Foods For Health Portfolio Of Functional Food Products: Effects On Lipid And Blood Glucose Management In Individuals Intolerant Of Statin (HMG-CoA Reductase Inhibitor) Therapy
Rochester, MN
The purpose of this study is to evaluate the ability of a range of new, easy to use, proprietary food based products to affect cardiovascular disease (CVD) risk factors by positively impacting blood cholesterol levels in statin intolerant and/or statin unwilling participants.
.